According to the Market Statsville Group (MSG), the Global lrinotecan Market size is expected to grow at a CAGR of 6.1% from 2023 to 2033.
Camptosar, also known as irinotecan, is a drug used in the treatment of cancers of the colon and the lungs. It can be used alone or in combination with fluorouracil to treat colon cancer. It is used with cisplatin to treat small cell lung cancer. Irinotecan is injected intravenously (into a vein) by a doctor or nurse during a 90-minute period. Irinotecan works as a topoisomerase I inhibitor. It operates by decreasing the action of topoisomerase I, an enzyme involved in DNA replication and repair. Irinotecan prevents the unwinding of DNA strands, resulting in DNA damage and eventually reducing the proliferation of cancer cells by blocking this enzyme.
The rising prevalence of colorectal cancer globally has been a major for the increase in the demand for Irinotecan drug. According to the World Health Organization (WHO), in 2023, colon cancer is the second leading cause of cancer-related deaths globally. By 2040 the burden of colorectal cancer is expected to increase by 63%, reaching to 3.2 million new cases per year and around 73% increase in the mortality rate, reaching to 1.6 million mortalities per year. Moreover, the breakthroughs in colorectal cancer diagnosis and treatment methodologies, as well as increased awareness among patients and healthcare professionals, have supported the growth of the Irinotecan market globally.
Based on type, the market is divided into irinotecan hydrochloride injection 40mg, irinotecan hydrochloride injection 100mg, and others. The irinotecan hydrochloride injection 40mg segment accounted for the largest market share in 2023. Irinotecan Hydrochloride Injection 40mg is a cancer medication that inhibits the growth and spread of cancer cells in the body. It is used to treat certain types of colorectal cancer, gastric cancer, and breast cancer, as well as other types of cancer, including small cell lung cancer, ovarian cancer, and non-small cell lung cancer, among others, depending on the type and stage of cancer, and other factors. And increasing amount of these cancer has boosted the segment growth over the forecasting period.
Based on the regions, the global lrinotecan market has been segmented across Europe, North America, the Middle East & Africa, Asia-Pacific, and South America. Asia Pacific accounted for the largest market share in 2023. The increasing number of cancer patients, supported by the rise in government initiatives for cancer awareness are some of the major factors driving the growth of the market in the region. Moreover, the increasing investment in oncology research and development in the region are all expected to fuel the growth of the Asia Pacific irinotecan market during the forecast period.
The Major key players in the global lrinotecan market are:
This market research study categorizes the lrinotecan market-based on type, distribution channel, end user, and application area at the regional and global levels.
Frequently Asked Questions
The lrinotecan market is expected to project a CAGR of 6.1% during the forecast period.
The main players involve in the market are Pfizer, Teva, Actiza Pharmaceutical, Getwell, Taj Pharma, Cipla, Salius, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Accord Healthcare, Mylan Pharmaceuticals, Other Companies, among others.
Opportunities in the irinotecan market include a growing demand for cancer treatments, potential advancements in personalized medicine, and expansion into emerging markets; however, risks encompass generic competition, evolving treatment approaches, and regulatory hurdles.
Key trends, innovations, and technological advancements in the irinotecan market include the development of targeted therapies, immunotherapies, and precision medicine approaches, as well as advancements in drug delivery systems to improve efficacy and reduce side effects.
Want to Review Complete Market Research Report
Budget constraints? Get in touch with us for special pricing
Request for Special PricingCustomize this Report
Related Reports
Metagenomics Sequencing Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Medical Cannabis Oil Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024Novel Vaccine Delivery System Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Lysosomal Storage Disease Treatment Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024Single-Use Bioprocessing Market 2022: Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033
Mar 2024